Peripheral diabetic neuropathy. Type 2 diabetes mellitus with neurological complications
Conditions
Interventions
Intervention 1: Intervention group: According to the recommendation of the International Association of Lymphology, daily treatment is carried out for 5 days a week and up to 10 sessions. 45 minutes o
Sponsors
Hamedan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
40 Years to 60 Years
Inclusion criteria
Inclusion criteria: Having type 2 diabetes Symptoms of peripheral neuropathy in the distal lower limbs Body mass index between 20 and 25 Duration of diabetes more than 5 years HbA1c between 6 and 8
Exclusion criteria
Exclusion criteria: Taking insulin Having diabetic foot ulcers Pregnancy Radiculopathy Having any other treatment for peripheral neuropathy in the past three months Having a skin infection or any skin disease
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain severity. Timepoint: First session (before intervention), and 10 day (after intervention). Method of measurement: Visual Analogue Scale.;Sense of touch. Timepoint: First session (before intervention), and 10 day (after intervention). Method of measurement: Semmes-Weinstein monofilament 5.07/10g.;Severity of neuropathy. Timepoint: First session (before intervention), and 10 day (after intervention). Method of measurement: Valk questionnaire.;Balance. Timepoint: First session (before intervention), and 10 day (after intervention). Method of measurement: Berg Balance Scale. | — |
Secondary
| Measure | Time frame |
|---|---|
| Blood suger. Timepoint: First session (before intervention), 5, and 10 day (after intervention). Method of measurement: Blood sugar measuring device. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMohammad Reza Asadi
Hamedan University of Medical Sciences
Outcome results
None listed